<h1 itemprop="aspect"> <strong>Gadopentetate Dimeglumine Side Effects</strong></h1><div class="thumbnail-div"> <img width="84" height="84" src="http://www.bad-drug.net/wp-content/uploads/2012/12/magnevist-84x84.jpg?1df917" class="attachment-84x84 wp-post-image" alt="Gadopentetate Dimeglumine" title="Gadopentetate Dimeglumine" pagespeed_url_hash="3530687557" onload="pagespeed.CriticalImages.checkImageForCriticality(this);"/></div><h1>Severe Side Effects of Gadopentetate Dimeglumine</h1><ul><li>Gadopentetate Dimeglumine and other gadolinium-based contrast agents may cause <strong>Nephrogenic Systemic Fibrosis </strong>when used in patients with renal failure.  Please refer to black box warning on this page.</li><li>This drug may cause <strong>severe convulsions</strong> including grand mal seizures.</li><li>Serious anaphylactic shock and allergic reactions have occured in some patients who used Gadopentetate Dimeglumine.</li><li><strong>Acute renal failure</strong> and worsening of kidney function may occur.</li></ul> &nbsp;<h2>Common Side Effects of Gadopentetate Dimeglumine</h2><ul><li>Gadopentetate Dimeglumine may cause migraines, abdominal pain, vomiting, loose stools, dry mouth, ear and eye pain, rash, anxiety, and irritated throat and nasal passages.</li></ul></div><div class="v" id="tab2" ><h2 itemprop="aspect"> <strong> Warnings & Recalls for Gadopentetate Dimeglumine </strong></h2><h2>Black Box Warning</h2><ul><li>On May 23rd, 2007, the <a href="http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm142884.htm" target="_blank" rel="nofollow"> FDA </a> issued an updated black box warning for all gadolinium-based contrast agents including Gadopentetate Dimeglumine.  These contrast agents may cause Nephrogenic Systemic Fibrosis, which is a<strong> life threatening form of Fibrosis that targets the skin, internal organs, joints, and eyes of the patient</strong>.</li><li>The patient should not take Gadopentetate Dimeglumine if he or she has renal impairment or any other kidney problems.</li></ul><h2>Other Warnings</h2><ul><li>Immediately discontinue use if an allergic reaction, hives, or anaphylactic shock occurs.</li><li>Patients with possible renal impairment should have creatine levels tested and kidney function screened before use.</li><li>The physician should observe caution when administering Gadopentetate Dimeglumine and observe the injection site for any allergic reactions.</li><li>Gadopentetate Dimeglumine is a <strong>pregnancy category class C</strong> drug.  The patient should observe caution when administered this drug while pregnant.  In a study using pregnant lab rats and rabbits, the drug slowed fetal development when administered over a period of 10 days.</li></ul> &nbsp;</div><div class="v" id="tab3" ><h2 itemprop="aspect"> <strong> Gadopentetate Dimeglumine Treatment and Use </strong></h2><div class="thumbnail-div"> <img width="84" height="84" src="http://www.bad-drug.net/wp-content/uploads/2012/12/magnevist-84x84.jpg?1df917" class="attachment-84x84 wp-post-image" alt="Gadopentetate Dimeglumine" title="Gadopentetate Dimeglumine" pagespeed_url_hash="3530687557" onload="pagespeed.CriticalImages.checkImageForCriticality(this);"/></div><p><strong>Gadopentetate Dimeglumine</strong> | Magnevist is an injectable contrast used with MRI scans (magnetic imaging resonance).  It is frequently used in adults and pediatric patients to <strong>identify lesions</strong> in the brain, neck, and spine which <strong>may indicate cancer, disease, or trauma</strong>.  A popular brand name of this drug called Magnevist is produced by <strong>Bayer Pharmaceuticals</strong>.</p><h2>What does Gadopentetate Dimeglumine do?</h2><p>When Gadopentetate Dimeglumine is within a magnetic field (such as an active MRI machine) it <strong>creates a magnetic moment and allows the target area to be imaged and diagnosed. </strong> This contrast in conjunction with the MRI machine allows the physician or specialist to identify tumors, lesions, and other abnormalities.  Gadopentetate Dimeglumine is a <a target="_blank" href="http://www.fda.gov/Drugs/DrugSafety/DrugSafetyNewsletter/ucm142889.htm" target="_blank" rel="nofollow"> gadolinium-based contrast </a> which includes other brands such as Omniscan, OptiMARK, MultiHance, and ProHance.<strong><br/> </strong></p><h2>Dosage</h2><p>The typical dose for Gadopentetate Dimeglumine is 0.2mL per kg or for every 2.2 lbs of weight via intravenous injection.  For example, a person who weighs 176 lbs should receive 16 mL.</p></div><div class="v" id="tab4" ><h2 itemprop="aspect"> Other Names for Gadopentetate Dimeglumine</h2><h2>Brand Name</h2><br/><ul><br/><li>Magnevist</li><br/></ul><br/><h2>Generic</h2><br/><ul><br/><li>Gadopentetate Dimeglumine</li><br/></ul></div><div class="v" id="tab5" ><h2 itemprop="aspect"> <strong> Lawsuits & Legal Information for Gadopentetate Dimeglumine </strong></h2>